One Dataset. One Platform. Endless Possibilities.
Your brand’s success depends on the quality of the data and insights you rely on. For emerging pharmaceutical manufacturers with limited resources, having a strategic partner who can deliver real-world data for pharma commercialization is critical.
MMIT and Panalgo, alongside our parent company Norstella, empower commercial and HEOR teams with integrated data, AI-powered healthcare analytics, and industry expertise. Through NorstellaLinQ, we provide analytics-ready, tokenized, and clinically validated real-world data that’s already linked across multiple sources—helping you move from insight to impact, faster.
Whether you’re in early development, preparing for commercialization, or navigating market access, MMIT and Panalgo are ready to meet you where you are and help take you where you need to go.
Add MMIT and Panalgo to Your Strategy
MMIT Can Help You
- Identify high-value patients before diagnosis
- Target prescribers based on clinical decisions, not just volume
- Uncover true HCP influence at the NPI level
- Eliminate market access barriers before they impact adoption
- Optimize field engagement with AI-curated physician sentiment
With Panalgo, You Can
- Leverage advanced, self-service analytics with the industry-leading IHD platform
- Conduct analyses at the speed of AI with Ella, Panalgo’s Gen AI assistant
- Produce credible, regulatory-grade and publication-ready evidence
- Leverage pharma’s most complete and connected data asset with NorstellaLinQ’s 74B+ data points
- Explore unstructured patient notes for deeper insights